GleamWall
中文EN

HCM HUTCHMED (China) Ltd

Pharmaceutical Preparations · Nasdaq · SEC CIK 1648257

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY-13.0%
TTM net income YoY1,111.0%
TTM EPS YoY1,200.0%
Revenue 3-yr CAGR8.8%
Net income 3-yr CAGR—

Margins

Gross margin38.7%
Operating margin-7.1%
Net margin83.3%
FCF margin-14.4%
EBITDA margin-4.7%

Returns

ROE45.7%
ROA30.2%
ROIC (approx.)-3.5%
Asset turnover0.36x

Leverage & solvency

Liabilities / assets28.6%
Debt / equity0.08x
Current ratio4.96x
Interest coverage-13.67x

Cash quality & payout

Operating cash flow / net income-0.14x
Accruals ratio34.5%
Payout ratio—
Capex / revenue2.6%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$548.51M$630.20M
Cost of revenue$336.35M$348.88M
Gross profit$212.16M$281.32M
R&D expense$148.29M$212.11M
SG&A expense$66.72M$64.30M
Operating income-$39.16M-$43.70M
Interest expense$2.87M$2.87M
Pretax income$498.69M-$1.11M
Income tax$63.61M$7.19M
Net income$456.91M$37.73M
EBITDA-$25.85M-$31.36M
EPS (basic)0.530.04
EPS (diluted)0.520.04
Weighted avg. shares (diluted)872.89M872.83M
Banking
Deposits$1.68M$1.63M
Balance sheet
Cash & equivalents$71.33M$153.96M
Short-term investments$1.30B$682.15M
Receivables$126.75M$155.54M
Inventory$41.13M$50.40M
Current assets$1.57B$1.07B
PP&E, net$94.62M$92.50M
Goodwill$3.11M$2.99M
Intangibles$8.94M—
Total assets$1.75B$1.27B
Current liabilities$315.77M$376.56M
Short-term debt$24.97M$23.37M
Long-term debt$68.19M$59.43M
Total debt$93.16M$82.81M
Total liabilities$501.83M$502.34M
Shareholders' equity$1.24B$759.93M
Net debt$21.83M-$71.15M
Cash flow statement
Operating cash flow-$64.66M$497,000
Capital expenditure$14.15M$17.93M
Free cash flow-$78.81M-$17.44M
Investing cash flow-$29.41M-$96.06M
Financing cash flow$7.84M-$30.67M
Depreciation & amortization$13.31M$12.34M
Share buybacks—$36.06M

Free plan shows the latest 2 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.